Johnson, Braden, et al. “Epidermal Growth Factor Receptor Inhibitor Treatment Timing Does Not Impact Survival in Stage 4 Colon Cancer Treatment: A Retrospective Study: EGFR Inhibitor Treatment Line Outcomes”. Kansas Journal of Medicine, vol. 15, no. 2, Aug. 2022, pp. 273-7, https://doi.org/10.17161/kjm.vol15.15975.